ÖZET Amaç: Bu çalışmada DSM-5 Bozuklukları için Yapılandırılmış Klinik Görüşme-Klinisyen Versiyonunun (SCID-5/CV) Türkçeye uyarlanması ve güvenilirliği araştırılmıştır.Yöntem: Araştırma iki üniversite hastanesinde ayaktan ya da yatarak tedavi alan 185 hastayla yürütülmüştür. SCID-5/ CV(KlinisyenVersiyonu)'nin özellikleri ve kullanımı konusunda eğitim toplantıları yapılması sonrasında, bir psikiyatrist görüşmeci iken diğeri gözlemci; diğer psikiyatrist görüşmeci iken diğeri gözlemci olacak şekilde uygulanmıştır. Görüşmeciler arası güvenilirlik araştırılmış ve Cohen kappa katsayısı hesaplanarak istatistiksel değerlendirme yapılmıştır. Bulgular:Hastaların yaş ortalaması 37,2±13,5'ti ve %55,7'si kadındı, %38,9'unun eğitim durumu yükseköğretim, %23,8'inin lise, %33'ünün ilköğretim, %1,6'sı okuryazar ve %2,7'si okuryazar değildi. Kappa katsayısının, şizofreni (κ=0,93), bipolar bozukluk (κ=0,96), major depresif bozukluk (κ=0,89), distimik bozukluk (κ=0,82), alkol kullanım bozukluğu (κ=0,96), panik bozukluğu (κ=0,84), agorafobi (κ=0,85), toplumsal kaygı bozukluğu (κ=0,95), yaygın anksiyete bozukluğu (κ=0,89), obsesif kompulsif bozukluk (κ=0,87), travma sonrası stres bozukluğu (κ=0,89), erişkin dikkat eksikliği ve hiperaktivite bozukluğu (κ=1,00), özgül fobi (κ=0,82) için mükemmel uyumu yansıttığı bulunmuş; bedensel belirti bozukluğu (κ=0,65) ve uyum bozukluğu (κ=0,78) için çok iyi uyumu yansıttığı bulunmuştur.Sonuç: Geçmiş SCID versiyonlarına benzer şekilde kappa katsayısı oldukça yüksek bulunmuştur ve hepsi istatistiksel olarak anlamlıdır. SCID-5/CV'nin Türkçe versiyonu hem günlük klinik pratikte hem de klinik çalışmalarda güvenilir bir şekilde kullanılabilir.Objective: In this study, we aimed to adapt the Structured Clinical Interview for DSM-5-ClinicianVersion into Turkish and to demonstrate its reliability. Method:A total of 185 patients, both inpatient and outpatient, from two different university hospitals were included. Training sessions on the features and use of SCID-5/CV were held before the data collection. During the study, in order to test the diagnostic agreement and accuracy, two psychiatrists remained present at the evaluation of each participant; alternatively being interviewer and the observer. Cohen's kappa coefficient for inter-rater reliability was calculated for every diagnostic category. Results:The patient group had a mean age of 37.2 (±13.5) years and 55.7% were female. The education status was as follows: 2.7% were illiterate, 1.7% literate with no primary education, 33% had primary education, 23.8% had secondary education and 38.9% had higher education. The calculated kappa value showed excellent agreement for schizophrenia (κ=0.93), bipolar disorder (κ=0.96), major depressive disorder (κ=0.89), dysthymic disorder (κ=0.82), alcohol use disorder (κ=0.96), panic disorder (κ=0.84), agoraphobia (κ=0.85), social anxiety disorder (κ=0.95), generalized anxiety disorder (κ=0.89), obsessive compulsive disorder (κ=0.87), posttraumatic stress disorder (κ=0.89), adult attention deficit and hyperactivity di...
Objective: Many individuals with cigarette addiction are known for beginning to smoke cigarettes during adolescence years. In this study, we aimed to present the clinical outcomes of smoking cessation project conducted in an Anatolian school in Kartal district of Istanbul, Turkey. Methods: Social and motivational studies were carried out on adolescent smokers after scanning in terms of smoking in an Anatolian school and 44 of these adolescents who are clinical requirements were evaluated and followed by Chest disease and child and adolescent mental health for six months. Carbonmonoxide (CO) measurements in the expiratory air and carboximeter (piCO smokerlyzer, Bedfont Scientific Ltd, England) were made at the first visit and follow-up. Simultaneously, K-SADS PL (Schedule for Schizophrenia and Affective disorders for School Age Children) was administered diagnostically in mental health evaluation. Results: A total of 44 adolescents, 13 girl (29.5%) and 31 boy (70.5%), with a mean age of 17.31 were followed up. The mean age of initiation of cigarette smoking was 14.2 ± 1 and 32 (82.7%) adolescent were found to have at least one smoker in their home. While 22.7% of adolescents did not try smoking cessation, 77.3% of them did. Six of these adolescents indicated that they did not smoke during the six months; 55.5% of these adolescents have at least one mental illness; the most common diagnoses were 25.0% (n = 11) of ADHD (Attention Deficit Hyperactivity Disorder) and 20% (10) of MD (Major Depression). While depression was significantly frequent in girls (p = 0.043), the frequency of ADHD was not significant in terms of gender. Depression presence was associated with early onset of cigarette smoking in males (p = 0.019), but not with females (p = 0.394). There was a statistically significant correlation between smoking cessation effort and age in the follow-up period (p = 0.022), and earlier adolescents stated that they wanted to quit smoking more. While there is no significant association between smoking cessation effort and mental disease, there was a statistically close relation with parent and sibling smoking (p = 0.07) and significant correlation with motivation and smoking cessation effort (p = 0.016). Conclusions: Smoking cessation work in adolescents is much more difficult than in adults. Biological and social factors and peer impact influence interventions. In our study, very few adolescents stated to quit smoking for 6 months, and the rate of psychiatric illnesses among adolescents and the presence of individuals smoking at home were found to be quite high. It has been the result of these factors also affecting the success of adolescents to start smoking and to quit smoking.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.